#806 — The Industry Wire

June 3, 2026 Brian Casey 0 min read
  1. Massachusetts sues UnitedHealthcare for Medicaid fraud.
  2. CMS publishes Medicaid work requirements.
  3. As AI adoption surges, providers worry about deskilling.
  4. Daraxonrasib is a success for pancreatic cancer.
  5. FTC forces Ascension to divest in $3.9B AmSurg deal.
  6. Maybe GLP-1s lower breast cancer risk?
  7. Presbyterian pulls back from Medicare Advantage.
  8. Eli Lilly’s data sharing ultimatum for 340B hospitals.
  9. NYU Langone’s massive Long Island hospital plans.
  10. Ardent Health appoints new president, CEO.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Imaging IT June 15, 2026

Top Trends from SIIM 2026 June 15, 2026

The SIIM 2026 conference demonstrated once again radiology’s ongoing evolution, from a discipline once known for big iron to one dominated by software.

Artificial Intelligence June 11, 2026

AI for Breast Cancer Risk June 11, 2026

AI may be able to identify subtle mammographic signs of breast cancer years before conventional diagnosis.

Radiologists June 8, 2026

Radiology’s ‘Zombie Jobs’ Go Unfilled June 8, 2026

A new report suggests that radiologist job shortages are mostly isolated to areas that radiologists don’t want to move to.